Relation of serum α- and γ-tocopherol levels to cardiovascular disease-related mortality among japanese men and women

Journal of Epidemiology

Volumn 22, Issue 5, 2012, Pages 402-410

  Nagao, Masanori ^a,b   Moriyama, Yuri ^c   Yamagishi, Kazumasa ^d   Iso, Hiroyasu ^a   Tamakoshi, Akiko ^e  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c The Public Health Institute of Kochi Prefecture   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

tocopherol; tocopherol; Cardiovascular disease; Nested casecontrol study; Prospective study; Stroke; Vitamin e

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; GAMMA TOCOPHEROL;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; FEMALE; FOLLOW UP; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO;

ADULT; AGED; ALPHA-TOCOPHEROL; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GAMMA-TOCOPHEROL; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84867161246     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120002     Document Type: Article

References (45)

1. Clarke MW, Burnett JR, Croft KD. Vitamin E in human health and disease. Crit Rev Clin Lab Sci. 2008;45:417-50.
2. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-6.
3. Leppälä JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, et al. Controlled trial of alpha-tocopherol and beta- carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol. 2000;20:230-5.
4. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123-33.
5. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:56-65.
6. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-60.
7. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al; HOPE and HOPE-TOOTrial Investigators. Effects of long-term Nagao M, et al. 409 vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-47.
8. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-9.
9. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med. 1993;328:1450-6.
10. VokÓ Z, Hollander M, Hofman A, Koudstaal PJ, Breteler MM. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology. 2003;61:1273-5.
11. Del Rio D, Agnoli C, Pellegrini N, Krogh V, Brighenti F, Mazzeo T, et al. Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr. 2011;141:118-23.
12. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000;72:476-83.
13. Clarke MW, Burnett JR, Wu JH, Hodgson JM, Ledowski T, Puddey IB, et al. Vitamin E supplementation and hepatic drug metabolism in humans. J Cardiovasc Pharmacol. 2009;54:491-6. 14.
14. Landes N, Pfl{ligature}uger P, Kluth D, Birringer M, Rühl R, Böl GF, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol. 2003;65:269-73.
15. Cai Y, Konishi T, Han G, Campwala KH, French SW, Wan YJ. The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways. Eur J Pharm Sci. 2002;15:89-96. 16. Brigelius-Fl{Ligature}ohé R. Induction of drug metabolizing enzymes by vitamin E. J PlantPhysiol. 2005;162:797-802.
16. Brigelius-Fl{Ligature}ohé R. Induction of drug metabolizing enzymes by vitamin E. J PlantPhysiol. 2005;162:797-802.
17. Parker RS, Sontag TJ, Swanson JE. Cytochrome P4503A- dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun. 2000;277:531-4.
18. LeppÄlÄ JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30: 2535-40.
19. Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, et al. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specifi{ligature}c mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 2006;84:1200-7.
20. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004;35:1584-8.
21. Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation. 2003;108:802-7.
22. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid solubleantioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998;147:180-6.
23. Ohno Y, Tamakoshi A; JACC Study Group. Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study). J Epidemiol. 2001;11:144-50.
24. Tamakoshi A, Yoshimura T, Inaba Y, Ito Y, Watanabe Y, Fukuda K, et al; JACC Study Group. Profi{ligature}le of the JACC study. J Epidemiol. 2005;15 Suppl 1:S4-8.
25. Tamakoshi A, Suzuki K, Ito Y, Watanabe Y, Inaba Y, Tajima K, et al; JACC Study Group. Selection of cases and controls for the nested case-control study within the Japan Collaborative Cohort Study: the First-wave. Asian Pac J Cancer Prev. 2009;10 Suppl:1-5.
26. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, et al; JACC Study Group. Serum total cholesterol levels and risk of mortality from stroke and coronary heart diseasein Japanese: the JACC study. Atherosclerosis. 2007;194:415-20.
27. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL- cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb. 2003;10:145-53.
28. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65 Suppl 4:1220S-31S.
29. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 1999;13: 977-94.
30. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a signifi{ligature}cant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J NeurolSci. 1993;116:135-41.
31. Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke. 1988;19:205-10.
32. Kumar S, Goddeau RP Jr, Selim MH, Thomas A, Schlaug G, Alhazzani A, et al. Atraumaticconvexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology. 2010 Mar 16;74:893-9.
33. Wisniewski HM, Wegiel J, Vorbrodt AW, Mazur-Kolecka B, Frackowiak J. Source. Role of perivascular cells and myocytes in vascular amyloidosis. Ann N Y Acad Sci. 2000;903:6-18.
34. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, et al. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 2004;18: 323-5.
35. Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T, et al. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation. 2007 Dec 11;116:2830-40.
36. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. FreeRadic Biol Med. 2010 Mar 15;48: 749-62.
37. Aoki T, Nishimura M, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavengeredaravone and p47phox(-/-) mice. Lab Invest. 2009;89:730-41.
38. Kitamura A, Nakagawa Y, Sato M, Iso H, Sato S, Imano H, et al. Proportions of stroke subtypes among men and women≥ years of age in an urban Japanese city in 1992, 1997, and 2002. Stroke. 2006;37:1374-8.
39. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003;77:700-6.
40. Saldeen T, Li D, Mehta JL. Differential effects of alphaand gamma-tocopherol on low-density lipoprotein oxida-tion, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol. 1999;34:1208-15.
41. Gutierrez AD, de Serna DG, Robinson I, Schade DS. The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism. 2009;58:469-78.
42. Traber MG, Kayden HJ. Preferential incorporation of alpha- tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr. 1989;49:517-26.
43. Comstock GW, Alberg AJ, Helzlsouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, betacarotene, and alpha-tocopherol in serum or plasma summarized. Clin Chem. 1993;39:1075-8.
44. Iso H, Jacobs DR Jr, Goldman L. Accuracy of death certifi{ligature}cate diagnosis of intracranial hemorrhage and nonhemorrhagic stroke. The Minnesota Heart Survey. Am J Epidemiol. 1990;132:993-8.
45. Yamashita T, Ozawa H, Aono H, Hosokawa H, Saito I, Ikebe T. Heart disease deaths on death certifi{ligature}cates re-evaluated by clinical records in a Japanese city. Jpn Circ J. 1997;61:331-8.